Precision Business Insights
Portfolio

 

Research Reports

Ophthalmic Viscoelastic Devices (OVDs) Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Ophthalmic Viscoelastic Devices (OVDs) Market by Type (Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD)), By Application (Vitreoretinal Surgery, Glaucoma Surgery, Cataract Surgery, and Corneal Transplantation), By End User (Hospitals, Ophthalmology Clinics, and Others), and Geography.

 

Market Outline: Ophthalmic Viscoelastic Devices (OVDs) Market

 

Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC).

 

Increase in the prevalence of eye diseases and rise in the number of cataract and glaucoma surgeries are driving the growth of ophthalmic viscoelastic devices (OVDs) market. The favorable reimbursement policies for surgeries using ophthalmic viscoelastic devices (OVDs) and strategic approach of the manufacturers help them sustain the growth and expansion in the market. The collaborations, mergers and acquisitions among vendors are helping to drive the R&D activities which are expected to create the market growth. However, the availability of alternate therapies, poor healthcare infrastructure, and the lack of awareness among the healthcare fraternity may hinder the growth of the ophthalmic viscoelastic devices (OVDs) market over the forecast period.

 

Global ophthalmic viscoelastic devices market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Scope: Ophthalmic Viscoelastic Devices (OVDs) Market

 

Ophthalmic viscoelastic devices market is segmented based on the type, application, end user, and region

Based on the type, the market is segmented into the following:

  • Cohesive ophthalmic viscoelastic devices (OVD)
  • Dispersive ophthalmic viscoelastic devices (OVD)

 

Based on the application, the market is segmented into the following:

  • Vitreoretinal Surgery
  • Glaucoma Surgery
  • Cataract Surgery
  • Corneal Transplantation

 

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ophthalmic clinics
  • Others

 

Regional Analysis:  Ophthalmic Viscoelastic Devices (OVDs) Market

Geographically, global ophthalmic viscoelastic devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America ophthalmic viscoelastic devices market growth driven by increase in the prevalence of eye diseases. The growing geriatric population and higher adoption of the newer technology expected to drive the market growth in the region. Falling in the second place is the European region. The growing awareness about the advanced treatments among the patient population and large disposable income is emerging markets in the region driving the market revenue growth. The Asia Pacific region is expected to be growing faster over the forecast period.

 

Competition Assessment: Ophthalmic Viscoelastic Devices (OVDs) Market

  • Johnson & Johnson ((U.S)
  • Alcon Laboratories Inc. (Switzerland)
  • Bausch & Lomb (U.S)
  • Carl Zeiss AG (Germany)
  • Rayner Company (UK)
  • Bohus BioTech AB (Sweden)
  • Lifecore Biomedical LLC (U.S)

 

Notable Market Developments:

  • In July 2015, Rayner Surgical Group Limited (‘Rayner’), the pioneering manufacturer of intraocular lenses for cataract surgery, has acquired the ophthalmic cataract surgery business of Aptissen SA (Geneva, Switzerland)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Johnson & Johnson ((U.S)
  • Alcon Laboratories Inc. (Switzerland)
  • Bausch & Lomb (U.S)
  • Carl Zeiss AG (Germany)
  • Rayner Company (UK)
  • Bohus BioTech AB (Sweden)
  • Lifecore Biomedical LLC (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

Ask An Analyst